| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Remestemcel-L-rknd (Ryoncil) | 2025-10-01 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Margetuximab-cmkb (Margenza) | 2025-10-01 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Ixabepilone (Ixempra) | 2025-10-01 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Datopotamab deruxtecan-dlnk (Datroway) | 2025-10-01 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Ado-trastuzumab emtansine (Kadcyla) | 2025-10-01 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Docetaxel (Taxotere) | 2025-10-01 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Pertuzumab (Perjeta) | 2025-10-01 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Natalizumab (Tysabri) | 2025-10-01 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Fulvestrant (Faslodex) | 2025-10-01 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Lumasiran (Oxlumo) | 2025-10-01 |